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The apparent molecular size of the native a-crystallin B in cytosol preparations from rat heart, brain and retina was determined by gel permeation 
chromatography, detecting the protein by immunochemical ssay (ELISA), using an a-crystallin specific antiserum. Native a-crystallin from cytosol 
preparations of rat lens cortex was used as a reference. a-Crystallin B present in all three cytosol preparations from non-lenticular tissues eluted 
in a single symmetrical peak, with the same elution volume as a-crystallin from lens cortex cytosol preparations, corresponding to an apparent 
average molecular size of 0.8 x 106 Da. No other species could be detected. The results indicate that the a-crystallin aggregates characterized by 
an apparent average molecular mass of 0.8 x 106 Da, and considered to be the native, physiological form of the protein in the lens, are indeed 
not specific to lens tissue. Furthermore, the size of these a-crystallin aggregates i independent of their polypeptide composition. Aggregates found 
m the lens, composed of aA and aB polypeptides and their respective phosphorylated forms aA, and aB,, are similar in size to those found in 
heart, brain and retina, containing the aB but not the aA polypeptide. 
Lens protein; a-Crystallin; Protein structure; Protein aggregation 
1. INTRODUCTION 
cr-Crystallin is a major protein found in the lenses of 
all vertebrate animals [l-3]. The native protein present 
in the soluble fractions of lens fiber cells has an ap- 
parent molecular mass of approximately 0.8 x lo6 Da 
[4,5]. Isoelectric focusing analysis of the isolated pro- 
tein resolves, under denaturing conditions, four major 
polypeptides, CYA, CYAN, UB and &BP, which have a 
molecular mass of approximately 20 x lo3 [6]. The (YA 
and cuB polypeptides from the bovine lens have 57% 
homology in their amino acid sequences [7,8] and are 
the primary products from two different genes [9]. In 
the bovine, and probably in all mammals, specific 
phosphorylation reactions account for the major post- 
translational modification that these polypeptides 
undergo in vivo. Thus, crA, and cuB, are the 
phosphorylated forms of the respective primary gene 
products [lo]. 
The biological function of cu-crystallin in the lens is 
not known. It is believed that the protein has a struc- 
tural function related to the physical properties of the 
transparent lens tissue [l 11, a function thought to be 
associated with the particular molecular structure of 
Correspondence address: R. Chiesa, Biochemistry and Molecular 
Biology Laboratory, Department of Ophthalmology, Columbia 
University, 630 West 168th Street, New York, NY 10032, USA 
222 
Published by Elsevier Science Publishers B. V. (Biomedical Division) 
00145793/90/$3.50 0 1990 Federation of European Biochemical Societies 
this protein [ 12,131. Because cu-crystallin has not been 
crystallized, its tridimensional molecular structure re- 
mains unknown. Based on theoretical analysis of the 
amino acid sequences of the aA and aB polypeptides 
and nucleotide sequences of their respective genes, 
models have been proposed to describe the tertiary 
structure of these polypeptides [ 14,151. Furthermore, 
based on physiochemical studies, models have been 
proposed to describe a quaternary structure in the 
native protein [ 16- 181. 
Whereas the in vivo structure of a-crystallin in the 
lens has been conceptualized in terms of specific ar- 
rangements of both aA and aB polypeptides, the role 
that each polypeptide plays in the 0.8 x lo6 Da cy- 
crystallin aggregate is unknown. Work from several 
laboratories has demonstrated that the cuB polypeptide 
is expressed in various non-lenticular tissues [19-211. 
In contrast, the expression of the CXA polypeptide has 
only been detected in the lens and is, therefore, con- 
sidered lens specific. Thus, the non-lenticular tissues 
that express cu-crystallin B provide an attractive ex- 
perimental system to study the structure of a native ‘a- 
crystallin macromolecule’ composed of a single type of 
polypeptide chain. 
The present communication describes the determina- 
tion of the apparent average molecular size of native LY- 
crystallin B in cytosol preparations from three non- 
lenticular rat tissues, heart muscle, brain and retina, us- 
ing gel permeation chromatography. 
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Fig. 1. Gel permeation chromatography elution profiles of the cytosol proteins from four rat tissues. The amounts of protein fractionated were: 
lens cortex, 25 fig; heart and brain, 250 pg; retina, 50 pg. The protein elution profiles were obtained by absorbance at 280 nm. The cu-crystallin 
ELISA profiles were obtained by immunochemical nalysis of the column eluent, using an cu-crystallin specific antiserum. Eluents from heart, 
brain and retina preparations were analyzed directly whereas the eluent from the lens cortex preparation was diluted 1: 100. The absorbance at 
410 nm is proportional to the amount of cu-crystallin antigen in the eluent. The crystallins elution peaks are indicated in the protein elution profile 
from lens cortex. The peak eluting at 8 ml observed in the chromatograms of all three non-lenticular tissues corresponds to the void volume of 
the column and, according to the specifications of the manufacturer, contains components with apparent molecular size larger than 25 x lo6 Da. 
The elution volume of the standard ferritin (Mr 0.45 x 106) was 14 ml. 
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2. MATERIALS AND METHODS 
2.1. Tissue preparation 
All tissues were obtained from Sprague-Dawley rats weighing ap- 
proximately 250 g (Charles River). After euthanasia by cervical 
dislocation, brain, heart and eyes were dissected and placed in 
beakers containing 10 ml of ice-cold phosphate-buffered saline 
(PBS). Brain, heart and retina were minced into approximately 
2-3 mm pieces, and rinsed 2 times with 10 ml of ice-cold PBS to 
remove any blood. Lenses were dissected from the eyes and also rins- 
ed in PBS. Brain and heart tissues (approximately half the total organ 
wet weight), whole retinas (neuroretina), and the outer cortex of the 
lenses (excluding the lens capsule and composed of approximately 
30% of the wet weight) were homogenized at 4°C by hand with an 
all glass Potter Elvejhem homogenizer in 1.5 ml of 10 mM Hepes, 
0.25 M sucrose, pH 7.5, previously filtered through a 0.2 pm filter. 
The homogenates were centrifuged at 105000 x g for 45 min at 4°C. 
Protein concentrations of the resultant supernatants (cytosol frac- 
tions) were estimated by absorbance measurement at 280 nm. 
2.2. Gel filtration chromatography and detection of cu-crystallin 
The protein concentrations in cytosol fractions from lens cortex, 
heart, brain and retina were adjusted by dilution with homogeniza- 
tion buffer to 0.25, 2.5, 2.5 and 0.5 mg/ml, respectively. Aliquots of 
each cytosol sample (100 pl) were injected onto a gel filtration col- 
umn (Superose 6 HR10/30 prepacked, Pharmacia-LKB) previously 
equilibrated with 200 mM NaCl, 5 mM DTT, 50 mM Tris, pH 7.5. 
The column was eluted at 2O”C, at a flow rate of 0.5 ml/min and 
monitored by absorbance at 280 nm. The absorbance signal was ob- 
tained in a Gilson 112 UV/vis Absorbance Detector and acquired in 
a Macintosh SE computer using a data acquisition system and Analog 
Connection Work Bench version 2.0.2. The response of the system 
was linear up to 1 AU at 280 nm. Fractions (250~1) of the 
chromatographic eluent were collected directly into 96 well immuno- 
plates (Nunc MaxiSorp Flat Bottom Immuno Plates). cY-Crystallin 
was detected by the immunochemical assay ELISA. The samples 
from heart, brain and retina preparations were analyzed directly. The 
samples from rat lens cortex were diluted 1: 100 with elution buffer 
before analysis. Antigen was bound to the well surface at room 
temperature overnight, blocked with a 0.05% solution of Tween 20 
in phosphate buffered saline (TPBS) containing 3% bovine serum 
albumin (BSA/TPBS) for 30 min, and exposed to an anti cu-crystallin 
antiserum at a 1:500 dilution in BSA/TPBS, for 60 min. The 
polyclonal antiserum I.D. 23.1 prepared at this laboratory was used. 
This antiserum was raised in rabbit against total bovine cu-crystallin 
(0.8 x lo6 Da aggregate), prepared from bovine lenses [22]. The 
analysis of this antiserum by Western blot has demonstrated that it 
is specific for cu-crystallin, and recognizes, in addition to the (YA and 
aB polypeptides of the bovine protein, the aA, CYA,“~ and ruB 
polypeptides from the rat lens protein. The plates were washed with 
TPBS, blocked with BSA/TPBS, and then exposed to goat anti- 
rabbit IgG conjugated to horseradish peroxidase (BioRad), 1:2000 
dilution in BSA/TPBS. The color was developed using a Peroxidase 
Substrate Kit (BioRad), with Hz02 and 2,2 ’ -azino-di- 
(3-ethylbenzthiazoline-6-sulfonic acid) for 10 min and stopping the 
reaction by adding oxalic acid to a 1% final concentration. Quantita- 
tion was carried out by measurement of the absorbance at 410 nm, 
in a microplate reader. 
3. RESULTS 
In order to determine the molecular size of the native 
soluble cu-crystallin B, gel permeation chromatography 
analysis was carried out in cytosol fractions prepared 
from heart muscle, brain, retina, three rat tissues 
known to express the aB polypeptide but not the cuA 
[191. Cytosol preparations from rat lens cortex, cor- 
responding to differentiated lens fiber cells, and con- 
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taming a-crystallin aggregates composed of both aA 
and UB polypeptide chains, were simultaneously 
analyzed for comparative purposes. The cytosol 
preparations were fractionated by gel permeation 
FPLC, monitoring the elution simultaneously by absor- 
bance at 280 nm and an immunochemical assay 
(ELISA) using an antiserum specific for a-crystallin. 
The A280 elUtiOII PrOfileS of the cytosol preparations 
from the different tissues are shown in Fig. 1. The elu- 
tion profile of the proteins in the preparation from rat 
lens cortical fibers showed as expected, the 
characteristic pattern of lens soluble proteins, compris- 
ing the cy-, p&r-, PL-, ys- and y-crystallins (Fig. 1, pro- 
tein elution profile of lens cortex). Rat lens a-crystallin 
eluted as a single symmetrical peak at 12 ml, and 
coeluted with cu-crystallin from bovine lens cortex (data 
not shown), corresponding to an average apparent 
molecular size of 0.8 x lo6 Da [4,5]. 
The &so elution profiles of the soluble proteins from 
heart, brain and retina preparations were very different 
from that of the lens cortex preparations (Fig. 1, pro- 
tein elution profiles). Although significant absorbance 
readings were observed in the three preparations in the 
eluent at 12 ml, corresponding to a molecular size of 
0.8 x lo6 Da, no defined elution peak could be resolved 
in that range in any of the three preparations. 
To determine the elution pattern of a-crystallin B in 
the preparations of the three non-lenticular tissues, ali- 
quots of the chromatographic eluent from the columns 
were analyzed by a immunoassay (ELISA), using a 
specific a-crystallin antiserum (see section 2). The elu- 
tion profile of the heart, brain and retina preparations, 
obtained by this immunoassay resolved a single sym- 
metrical elution peak at 12 ml (Fig. 1, cu-crystallin 
ELISA profiles), corresponding to the a-crystallin peak 
observed in the elution profile of the lens cortex 
preparations (Fig. 1, cu-crystallin ELISA profile, lens 
cortex). Accordingly, an apparent molecular size of 0.8 
lo6 Da was assigned to the a-crystallin material in the 
elution peaks detected in the preparations of all three 
non-lenticular tissues. 
The results demonstrate that cu-crystallin B polypep- 
tides in cytosol preparations of rat heart, brain and 
retinal tissues, are present in an aggregated form which 
has an apparent molecular size of 0.8 x lo6 Da, in- 
distinguishable from that of rat or bovine lens (Y- 
crystallin. This appears to be the only form present in 
the cytosol of these non-lenticular tissues, since neither 
other sized aggregates nor free polypeptide chains 
could be demonstrated. 
4. DISCUSSION 
cu-Crystallin has been conceptualized as a lens- 
specific protein with a structural function in the lens, 
related specifically to the fundamental physiochemical 
properties of the tissue: transparency and refractive in- 
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dex. Such a specific structural function has been 
thought to be determined by a specific molecular struc- 
ture of the protein. It has been presumed that the in 
vivo structure of the protein in the lens is characterized 
by an apparent average molecular size of 0.8 x lo6 Da 
where both A and B polypeptide chains are constitutive 
monomers. The present work demonstrates the 
presence of native aggregates of a-crystallin polypep- 
tides in cytosol preparations from heart, brain and 
retina, indistinguishable in size from the aggregates 
present in lens tissue. If the property to form 0.8 x 
lo6 Da aggregates i  associated with the specific func- 
tion of cu-crystallin polypeptides in the lens, such a pro- 
perty would be expected to be specific for the lens 
protein, and moreover, the lens specific aA polypeptide 
would be expected to be required for the formation of 
such aggregates. Instead, aggregates of a-crystallin 
polypeptides are found in tissues other than the lens, 
and moreover, in these tissues the lens non-specific cuB 
polypeptide alone seems to be a sufficient requirement 
for the formation of the aggregates. 
Bhat and co-workers in two preliminary reports 
[23,24] described cwB aggregates in heart muscle and 
lens preparations with apparent molecular size of 0.3 x 
lo6 Da, determined by gel permeation chromato- 
graphy. Since the preliminary reports by these in- 
vestigators do not contain sufficient experimental 
details, it is difficult to discuss the discrepancy. It has 
been demonstrated that experimental conditions may 
affect the apparent molecular size of lens a-crystallin, 
giving lower apparent sizes [5]. It is, therefore, possible 
that the smaller apparent molecular size observed by 
Bhat and co-workers is due to the procedure utilized in 
the preparation and analysis of soluble tissue fractions. 
Because bovine lens c+crystallin aggregates with ap- 
parent average molecular size of 0.8 x lo6 Da have 
been isolated under physiological conditions of 
temperature, pH and ionic strength, it is believed that 
they occur in the intact tissue in vivo [5], a concept 
which is supported by indirect evidence from spec- 
troscopic studies of the lens tissue [25]. However, 
whether in the lens or in the other tissues, cu-crystallin 
aggregates are the result of particular interactions be- 
tween the constitutive polypeptide molecules. Such in- 
teractions are perhaps the consequence of artificial 
conditions of analysis, in particular, the disorganiza- 
tion of the cell structure. It is then possible that the 
0.8 x lo6 Da a-crystallin aggregates are unrelated to 
the structure in vivo which conveys the specific func- 
tion of the protein in a given tissue. 
Native cr-crystallin aggregates in soluble preparations 
from lens epithelial cells are indistinguishable in size 
from the native aggregates in lens fiber cell prepara- 
tions. Despite having the same apparent molecular size, 
0.8 x lo6 Da, the polypeptide compositions of these ag- 
gregates are different [26]. In the aggregates from 
epithelial cells only non-phosphorylated polypeptides 
are present (less than 0.1% of cvBp is present in these 
aggregates). In contrast, the aggregates from the fiber 
cell preparations, contain as much as 20% of 
phosphorylated polypeptide chains. These observations 
suggest hat phosphorylation has little or no effect on 
the apparent molecular size of the native protein, a 
view supported by recent physicochemical studies in- 
volving denaturation and renaturation of isolated (Y- 
crystallin polypeptides [27]. The results presented here 
indicate that the polypeptide type also has no effect on 
the overall structure of the native protein. Aggregates 
containing both aA and cuB chains have the same ap- 
parent average molecular size as those containing aB 
but not CUA. It should be noted, however, that the ex- 
periments described here do not allow for determining 
whether the (YB aggregates in the non-lenticular tissues 
are composed exclusively of aB polypeptides, or repre- 
sent associations of cuB polypeptides and other proteins 
such as cytoskeleton components. 
Preliminary experiments from this laboratory in- 
dicate that (YB phosphorylation also occurs in non- 
lenticular tissues. In vitro phosphorylation experiments 
in preparations from Alexander’s disease human brain, 
which is known to overexpress the protein, demon- 
strated a phosphorylated polypeptide with molecular 
weight (SDS-PAGE) and isoelectric point identical to 
those of bovine aB, [28]. Mouse and bovine heart ex- 
tracts appear to contain a charged form_ of cuB com- 
parable to lens aB, [29]. Whether the 0.8 x lo6 Da 
aggregates found in heart, brain and retina contain 
phosphorylated form(s) of the protein is not known at 
the present time. Experiments are being conducted to 
determine whether the aB polypeptide chains in these 
aggregates are phosphorylated, and if so, to what 
extent. 
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